Primary Job Title Member Of The Board Of Directors Primary Organization BlueWillow Biologics
Gender Male
David M. Stout is the Member Of The Board Of Directors at Nanobio.
David M. Stout has served as a top-level Pharmaceutical Executive both nationally and internationally for the past 30 years.
His most recent position was President of Pharmaceutical Operations for GlaxoSmithKline Pharmaceuticals. In this capacity, Mr. Stout led all global
commercial activities, global manufacturing and all vaccine-related activities for the company, including research and development. Additionally, Mr. Stout directed the corporate pandemic flu preparedness program, an international effort that supports governments, health authorities and company employees around the world in responding to a global influenza pandemic.
Prior to his tenure at GSK, Mr. Stout served as President of SmithKline Beecham’s North American pharmaceutical business, launching two major products and two sales force expansions.
Mr. Stout’s pharmaceutical career began at Warner-Lambert Pharmaceutical Company.
He continued at Schering-Plough Corporation, where he served in numerous positions, including President of Schering Laboratories.
